Live Chat: SERD Surge with Dr. Sherry Shen
Host Victoria, with Dr. Sherry Shen and co-host Ellen, delivers a concise, patient-focused overview of oral SERDs in HR+ metastatic breast cancer—covering ESR1 mutations, key trials (evERA, SERENA‑6), FDA‑approved agents, side-effect management, and treatment implications. This is the first episode in our Live Chats series. Bonus clip: Rebecca Shatsky, MD, previews the evERA trial and her excitement about combining capivasertib with oral SERDs.
MBC Insiders: MBC Awareness Day and More
This is a special episode released Oct 13 for National Metastatic Breast Cancer Awareness Day. It is the first in our recurring series, we call “MBC Insiders.” We’ll explore the issues that matter most to people with MBC, including how the language clinicians and media use can harm or help, and candid conversations about progression and the idea of “cure.” Stay tuned for an important, honest discussion.
Future at Risk: What Happens when Funding Stops
In the world where breakthrough cancer treatments hang in the balance, federal funding cuts are threatening to derail critical research that could save countless lives.
Our guest is Dr. Gloria Echeverria, a molecular biologist and passionate advocate for scientific discovery, who leads her own lab at Baylor College of Medicine. Her team investigates the molecular and genetic mechanisms that make TNBC resistant to standard treatments like chemotherapy and radiation.She shares what it’s like to run a research lab in today’s climate, the challenges of securing funding, and the ripple effects these cuts have on training the next generation of scientists, advancing new therapies, and supporting patient advocates.